Judith “Judy” Hope, aged 64, passed away on January 24, 2026, at UConn Health in Farmington after a brief but valiant battle with cancer. A lifelong...
Pentixapharm Holding AG has received encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding its planned Phase 3 PANDA study. The formal written minutes...
Ukrainian President Volodymyr Zelenskyy has expressed a willingness to abandon his country’s bid to join NATO in exchange for Western security guarantees. This announcement came as...
In a challenging year marked by setbacks, Moderna continues to advance its research in cancer therapies. The company announced on March 15, 2025, that its experimental...
At the European Society for Medical Oncology (ESMO) conference held in Berlin on October 15, 2023, China showcased significant advancements in cancer research, particularly in the...
Novartis is seeking to advance the use of its radiopharmaceutical, Pluvicto, in the treatment of prostate cancer, aiming for its application in earlier stages of the...
The latest edition of Endpoints Weekly highlights significant developments in the biopharmaceutical sector, including insights from John Carroll‘s third-quarter analysis, a discussion with a Nobel Prize...
Moderna, Inc. has announced promising early results from its investigational cancer therapy, mRNA-4359. This data will be presented at the 2025 European Society for Medical Oncology...
A series of significant cyber attacks have recently disrupted operations across multiple sectors, impacting several major European airports and luxury fashion brands. On September 22, 2023,...
Springer Nature is actively seeking a Locum Associate or Senior Editor for its Communications Physics division. The position is open in several major cities, including Shanghai,...
